Annual report pursuant to Section 13 and 15(d)

Stockholders' Deficit (Tables)

v3.20.2
Stockholders' Deficit (Tables)
12 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Schedule of Stock Warrant Activity

Warrant detail for the year ended June 30, 2020 is reflected below:

 

   

Number of

Warrants

   

Weighted

Average

Exercise

Price Per

Warrant

   

Remaining

Contract

Term (# years)

 
Warrants outstanding and exercisable at June 30, 2019     8,333     $ 20.00       0.25  
Warrants issued     83,205     $ 4.00       3.00  
Warrants exchanged     -     $ -       -  
Warrants forfeited     (8,333 )   $ 20.00          
Warrants outstanding and exercisable at June 30, 2020     83,205     $ 4.00       2.01  

 

Warrant detail for the year ended June 30, 2019 is reflected below:

 

   

Number of

Warrants

   

Weighted

Average

Exercise

Price Per

Warrant

   

Remaining

Contract

Term (# years)

 
Warrants outstanding and exercisable at June 30, 2018     174,079     $ 20.30       0.74  
Warrants issued     -     $ -       -  
Warrants exchanged     (7,996 )   $ 14.80       -  
Warrants forfeited     (157,750 )   $ 19.93       -  
Warrants outstanding and exercisable at June 30, 2019     8,333     $ 20.00       0.25  

Schedule of Stock Options Activity

Activity in stock options during the year ended June 30, 2020 and related balances outstanding as of that date are reflected below:

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2019     580,171     $ 11.05       8.59  
Granted     19,272     $ 8.45          
Exercised     (5,249 )   $ 4.68          
Forfeited and cancelled     (14,610 )   $ 11.86          
Outstanding at June 30, 2020     579,584     $ 11.00       7.55  
Exercisable at June 30, 2020     454,156     $ 10.77       7.27  

 

Activity in stock options during the year ended June 30, 2019 and related balances outstanding as of that date are reflected below:

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2018     350,726     $ 8.38       8.87  
Granted     245,027     $ 14.45          
Exercised     -     $ -          
Forfeited and cancelled     (15,582 )   $ 4.64          
Outstanding at June 30, 2019     580,171     $ 11.05       8.59  
Exercisable at June 30, 2019     303,611     $ 10.02       8.01  

Schedule of Stock-Based Compensation Expenses

We allocated stock-based compensation expense included in the consolidated statements of operations for employee option grants and non-employee option grants as follows:

 

Years ended June 30,   2020     2019  
Research and development   $ 215,000     $ 314,000  
Selling and administrative     1,588,000       1,630,000  
Total stock-based compensation expense   $ 1,803,000     $ 1,944,000  

Schedule of Fair Value Assumptions of Stock Options

The fair value of stock options was measured at the grant date using the assumptions (annualized percentages) in the table below:

 

Years ended June 30,   2020     2019  
Expected volatility     100.6% - 119.6 %     111.4% -112.2 %
Risk free interest rate     0.35% - 2.00 %     2.43% - 2.45 %
Forfeiture rate     20 %     20 %
Dividend yield     0 %     0 %
Expected term (years)     6.35       5.61